Mesirow Institutional Investment Management’s Surgery Partners SGRY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
$14.3M Buy
677,464
+77,603
+13% +$2.04M 1.1% 38
2024
Q3
$19.3M Buy
599,861
+82,894
+16% +$2.45M 1.48% 9
2024
Q2
$12.3M Buy
+516,967
New +$13.3M 1.08% 44
2024
Q1
Sell
-3,388
Closed -$108K 134
2023
Q4
$108K Buy
3,388
+373
+12% +$10.8K 0.01% 113
2023
Q3
$88.2K Hold
3,015
0.01% 118
2023
Q2
$136K Sell
3,015
-1,455
-33% -$55.5K 0.01% 114
2023
Q1
$154K Buy
+4,470
New +$145K 0.02% 141

Other funds holding SGRY

Mesirow Institutional Investment Management's SGRY Position: Q4 2024 in Review

Mesirow Institutional Investment Management increased its Surgery Partners (SGRY) stake by 13% in Q4 2024, buying an estimated $2.04M and bringing the position to 677,464 shares worth $14.3M. The position accounts for 1.1% of the portfolio, ranked #38.

Mesirow Institutional Investment Management first reported a position in SGRY in Q1 2023 and has held it in 7 quarters since. The position peaked at $19.3M in Q3 2024. 182 funds tracked by Wall St. Rank hold SGRY as of Q4 2024.

  • Mesirow Institutional Investment Management held 677,464 shares of Surgery Partners worth $14.3M as of Q4 2024.
  • Mesirow Institutional Investment Management bought 77,603 Surgery Partners shares in Q4 2024, an estimated $2.04M.
  • Surgery Partners made up 1.1% of Mesirow Institutional Investment Management's portfolio in Q4 2024, its #38 holding.
  • Mesirow Institutional Investment Management first reported a position in Surgery Partners in Q1 2023 and has held it in 7 quarters since.
  • Mesirow Institutional Investment Management's Surgery Partners position peaked at $19.3M in Q3 2024.
  • 182 funds tracked by Wall St. Rank held Surgery Partners as of Q4 2024.

Based on Mesirow Institutional Investment Management's 13F filing for Q4 2024, filed 13 Feb 2025.